EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Diagnostic Potential of miR‑451a in Myelodysplastic Syndromes

Ilina Micheva, Svilena Atanasova

Scripta Scientifica Medica · 2025

DOI: 10.14748/775sfj75 ↗
AbstractBibliografische Angaben

Abstract

Introduction:Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic disorders characterized by ineffective hematopoiesis and a risk of progression to acute myeloid leukemia. Diagnosis often requires integrating clinical, morphological, and genetic data, but distinguishing MDS from overlapping conditions remains challenging. MiR-451a plays a crucial role in erythropoiesis and has shown potential as a diagnostic biomarker, though existing data on its expression in MDS are conflicting. Aim:The aim of the study is to evaluate miR-451a expression levels in MDS patients and healthy controls and to assess variations in expression among different MDS subgroups. Materials and Methods: Plasma samples from 40 MDS patients and 10 healthy controls were analyzed for the expression levels of miR-451a using quantitative real-time PCR (qPCR). Statistical analysis was performed to compare expression levels between the groups. Results:MiR-451a levels were significantly lower in MDS patients compared to healthy controls (median 0.8215 vs. 2.132; p < 0.0001). ROC analysis revealed high diagnostic accuracy (AUC = 0.9175), with a threshold of 1.161 providing 70.0% sensitivity and 100.0% specificity. Additionally, miR-451a levels were significantly lower in low-risk MDS patients compared to high-risk patients (p = 0.0449). A moderate positive correlation was observed between miR-451a and ferritin (p < 0.05), suggesting a link with iron metabolism. Conclusion:Our findings demonstrate that miR-451a is significantly downregulated in MDS patients, highlighting its potential as a diagnostic biomarker. While its prognostic utility remains uncertain, miR-451a shows promise for non-invasive diagnosis.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →